Novodigal


Indications and Reactions:

Role Indications Reactions
Secondary
Supraventricular Tachycardia 10.1%
Epilepsy 8.9%
Chronic Obstructive Pulmonary Disease 8.3%
Dermatitis 8.1%
Rash 8.1%
Thrombosis Prophylaxis 7.2%
Tachycardia Paroxysmal 6.2%
Conjunctivitis 5.2%
Cardiac Failure 5.0%
Grand Mal Convulsion 4.7%
Drug Use For Unknown Indication 3.7%
Hypertension 3.1%
Essential Hypertension 2.7%
Nausea 2.7%
Product Used For Unknown Indication 2.7%
Pruritus 2.7%
Sleep Disorder 2.7%
Vomiting 2.7%
Hyperuricaemia 2.5%
Incontinence 2.5%
Toxic Epidermal Necrolysis 36.6%
Stevens-johnson Syndrome 22.0%
Renal Failure Acute 4.9%
Suicide Attempt 4.9%
Therapeutic Agent Toxicity 4.9%
Traumatic Haematoma 4.9%
Vein Disorder 4.9%
Hypoalbuminaemia 2.4%
Liver Function Test Abnormal 2.4%
Mastitis 2.4%
Multi-organ Failure 2.4%
Pruritus 2.4%
Somnolence 2.4%
Venous Thrombosis 2.4%
Concomitant
Product Used For Unknown Indication 18.0%
Hypertension 12.4%
Drug Use For Unknown Indication 10.5%
Atrial Fibrillation 9.3%
Rheumatoid Arthritis 5.0%
Type 2 Diabetes Mellitus 4.3%
Pain 4.0%
Prostate Cancer 3.7%
Breast Cancer 3.4%
Depression 3.4%
Pulmonary Hypertension 3.1%
Cardiac Failure 2.8%
Metastatic Renal Cell Carcinoma 2.8%
Non-small Cell Lung Cancer 2.8%
Parkinson's Disease 2.8%
Prophylaxis 2.8%
Tachyarrhythmia 2.8%
Arrhythmia 2.2%
Breast Cancer Metastatic 2.2%
Asthma 1.9%
Sick Sinus Syndrome 12.7%
Pain In Extremity 6.3%
Renin Increased 6.3%
Thrombocytopenia 6.3%
Vomiting 6.3%
Death 4.8%
Fall 4.8%
Gallbladder Cancer 4.8%
International Normalised Ratio Increased 4.8%
Parkinson's Disease 4.8%
Right Ventricular Failure 4.8%
Somnolence 4.8%
Toxic Epidermal Necrolysis 4.8%
Ventricular Fibrillation 4.8%
Acute Hepatic Failure 3.2%
Agranulocytosis 3.2%
Blood Creatinine Increased 3.2%
Cerebrovascular Accident 3.2%
Dyspnoea Exertional 3.2%
Ejection Fraction Decreased 3.2%

Drug Data